Completed
Work plan
Work plan
Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.
Chemicals
- Acrolein
1. Nomination
1. Nomination
Phase status
CompletedAcrolein (2-propenal; acrylaldehyde) is used as a liquid herbicide to control submerged and floating weeds in irrigation canals and ditches. Acrolein is classified as a dangerous poison (Schedule 7) in the Standard for the Uniform Scheduling of Drugs and Poisons. Acrolein is registered for use in New South Wales, Queensland, Victoria and Western Australia only and is declared to be a restricted chemical product. Its use is limited to irrigation areas and is highly restricted.
Acrolein is toxic to fish and wildlife and therefore is a threat to any water source used by animals close to an application zone. It is also dangerous to humans through contact with skin, inhalation, ingestion or eye contact. Currently there is only one registered product (Magnacide H herbicide) that contains acrolein as the active constituent.
Magnacide H herbicide is a restricted chemical product to be applied only by authorised, trained operators using specialised application equipment. People wishing to use acrolein must be authorised by the relevant state or territory and have completed specific training to meet the control-of-use requirements.
2. Prioritisation
2. Prioritisation
Phase status
Completed
3. Scoping and work plan
3. Scoping and work plan
Phase status
Completed
4. Notice of reconsideration
4. Notice of reconsideration
Phase status
Completed
5. Assessment
5. Assessment
Phase status
CompletedAn assessment of the concerns was undertaken in 1997, and resulted in the voluntary withdrawal of the majority of registered products as well as restrictions being placed on the label of the remaining product. The label for the remaining product was updated in 1997 and contains the required warning and precaution statements. There is no published report available for acrolein.
6. Proposed regulatory decision
6. Proposed regulatory decision
Phase status
CompletedThere are no published reports available for acrolein.